Lewes, DE -- (SBWire) -- 07/18/2017 --Report forecast the epilepsy therapeutic market in APAC to grow at a CAGR of 4.25% during the period 2017-2021.
Epilepsy is a neurological condition that affects the nervous system. It is characterized by the occurrence of two or more unprovoked seizures. A seizure is defined as the disruption of electrical communication between neurons. The central nervous system (CNS) disorders include several disorders and conditions such as epilepsy, Parkinson's disease, bipolar disorder, and depression.
The report covers the present scenario and the growth prospects of the epilepsy therapeutic market in APAC for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off label drugs.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
According to the report, one of the major drivers for this market is high unmet medical need. The epilepsy therapeutics market in APAC is currently witnessing a high unmet medical need in terms of the lack of any disease-modifying treatment. At present, drugs administered during epilepsy are intended to treat seizures, i.e., these are symptomatic in nature, which helps in suppressing symptoms (seizures) and provides substantial assistance to individuals.
Further, the report states that one of the major factors hindering the growth of this market is technological advancements in non-invasive neuromodulation and seizure management devices - A threat to drug therapies. A majority of the population treated with traditional AEDs still continue to suffer from their side effects such as weight gain, muscle spasm, blurred vision, dry mouth, and drowsiness. Hence, alternative methods were being investigated, and devices were developed for the individuals who do not respond to medications.
Epilepsy Therapeutic Market in APAC 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
key players in the epilepsy therapeutic market in APAC: Eisai, GlaxoSmithKline, Pfizer, and UCB.
Other Prominent Vendors in the market are: Dainippon Sumitomo Pharma and Janssen Pharmaceutical (a division of Johnson & Johnson).
Market driver
- High unmet medical need
- For a full, detailed list, view our report
Market challenge
- Technological advancements in non-invasive neuromodulation and seizure management devices - A threat to drug therapies
- For a full, detailed list, view our report
Market trend
- Reformulation of marketed drugs
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Spanning over 81 pages "Epilepsy Therapeutic Market in APAC 2017 - 2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Disease overview, Pipeline analysis, Market segmentation based on product type, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.
Please visit this link for more details: http://www.marketresearchreports.com/technavio/epilepsy-therapeutic-market-apac-2017-2021
Related Reports;
Global Safety Needles Market 2017-2021 - Visit at - http://www.marketresearchreports.com/technavio/global-safety-needles-market-2017-2021
Global Urinalysis Market 2017-2021 - Visit at - http://www.marketresearchreports.com/technavio/global-urinalysis-market-2017-2021
Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare
About Market Research Reports, Inc.
Market Research Reports® Inc. is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.
Contact us for your market research requirements: http://www.marketresearchreports.com/contact
